CBO releases estimates for ‘opioid crisis’ bill
The Congressional Budget Office (CBO) has released a spending/revenue estimates summary for the ‘Opioid Crisis Response Act of 2018’ that it prepared for the U.S. Senate, which is expected to consider the measure this week.
CBO says that the legislation would have a “small impact for on-budget direct spending outlays, ranging from a $500,000 decrease to a $500,000 increase, over 10 years.”
CBO also notes that the bill’s single largest savings ($250 million over 10 years) would be related to a provision requiring electronic prescribing of Medicare Part D covered controlled substances, while the largest spending increase ($89 million over 10 years) would be related to improving the Medicare fee-for-service program.
The Senate will consider the measure as an amendment to opioid legislation that passed in the House. The Senate version includes provisions to: reauthorize funding for state opioid grants; enhance opioid-related activities at the National Institutes of Health and the Food and Drug Administration; provide funding for treatment, recovery and prevention; address Medicare and Medicaid opioid-related activities, including the use of telehealth services in Medicare and Medicaid and modifying the Open Payments program; and, address other priorities.
Click for CBO estimates for ‘Opioid Crisis Response Act’ legislation
Click for ‘Opioid Crisis Response Act’ legislation
Click for section-by-section summary of ‘Opioid Crisis Response Act’